Haverford Trust Co Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Haverford Trust Co decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 426,145 shares of the healthcare conglomerate's stock after selling 1,280 shares during the quarter. UnitedHealth Group comprises approximately 2.1% of Haverford Trust Co's investment portfolio, making the stock its 13th largest holding. Haverford Trust Co's holdings in UnitedHealth Group were worth $215,570,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $40,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on UNH shares. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Finally, Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $629.32.

Remove Ads

UnitedHealth Group Stock Performance

NYSE UNH traded down $2.92 during trading on Tuesday, hitting $513.58. 3,014,727 shares of the company's stock traded hands, compared to its average volume of 4,091,387. The stock has a market capitalization of $469.78 billion, a price-to-earnings ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The business has a 50 day moving average of $509.10 and a 200-day moving average of $545.56. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. The business's revenue for the quarter was up 6.8% on a year-over-year basis. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. UnitedHealth Group's payout ratio is currently 54.19%.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.